New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For ADI;CTRX;DISCA;EQIX;LBTYA;LMCA;REGN;SBAC;VRSK;WDC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | all recent news | >>
November 13, 2014
16:19 EDTDISCAMeritage Group reports 5.0% passive stake in Discovery
Subscribe for More Information
09:40 EDTWDCActive equity options trading
Subscribe for More Information
06:17 EDTDISCASony unveils PlayStation Vue, a cloud-based TV service
Subscribe for More Information
November 12, 2014
10:43 EDTDISCABernstein downgrades Discovery, Viacom, citing 'structural decline' in TV
Research firm Bernstein sees strong evidence that audiences of ad-supported TV have entered a period of "structural decline." The firm cut its rating on Discovery (DISCA), the owner of the Discovery Channel and Animal Planet cable stations, and Viacom (VIA,VIAB), which owns MTV and and Nickelodeon. The firm also cut its price target on CBS (CBS). WHAT'S NEW: Noting that audiences for ad-supported TV have fallen by unprecedented amounts for four months, Bernstein analyst Todd Juenger added that consumption of subscription video on demand, or SVOD, services continue to grow. Meanwhile, TV networks are seeing increased competition from Internet websites for ad dollars, limiting the ability of the networks to raise ad prices, Juenger stated. The profit margins and return on investment of content owners are likely to decline over time, the analyst believes. He downgraded Discovery to Market Perform from Outperform and set a $37 price target on the stock, and cut Viacom to Underperform from Market Perform, placing a $71 price target on that stock. Juenger reduced his price target on CBS to $55 from $60 and kept a Market Perform rating on the shares. He kept Outperform ratings on 21st Century Fox (FOXA), Disney (DIS), and Time Warner (TWX), saying that those are least affected by the trend, as they are less dependent than their peers on the American TV ad market and have a large amount of sports programming. PRICE ACTION: In mid-morning trading, Discovery lost 0.6% to $31.81, Viacom class A shares gained 0.6% to $70.09, CBS fell 0.7% to $51.48, Twenty-First Century Fox class A shares lost 0.5% to $34.75, Time Warner fell 0.5% to $77.69 and Disney was flat near $90 per share.
10:29 EDTVRSKEquifax and Argus announce strategic alliance
Equifax (EFX) announced that it has formed a strategic alliance with Argus Information and Advisory Services, a Verisk Analytics (VRSK) business. The companies announced a new solution, Primary Impact, which will help optimize demand deposit account acquisition and maximize portfolio growth and customer profitability for financial institutions.
10:00 EDTDISCAOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:13 EDTREGNBoston Biotech to hold a conference
Subscribe for More Information
08:02 EDTCTRXCredit Suisse to hold a conference
Subscribe for More Information
06:13 EDTDISCADiscovery downgraded at Bernstein
Subscribe for More Information
November 11, 2014
16:08 EDTDISCADiscovery downgraded to Market Perform from Outperform at Bernstein
Subscribe for More Information
10:14 EDTREGNRegeneron data reinforce blockbuster potential of dupilumab, says Piper Jaffray
Piper Jaffray believes the Phase IIb results for dupilumab in patients with moderate to severe asthma reported by Regeneron (REGN) and partner Sanofi (SNY) reinforce the broad potential of the drug in a range of allergic diseases. The firm reiterates its $416 price target and Overweight rating on shares of Regeneron.
10:00 EDTVRSKOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:10 EDTEQIXEquinix and Datapipe to provide managed solutions to Amazon Web Services
Subscribe for More Information
06:09 EDTVRSKVerisk Analytics downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank downgraded Verisk Analytics to Hold citing the recent rally in shares and expectations for slower U.S. Medicare Advantage enrollment growth in 2015. The firm lowered its price target for shares to $67 from $68.
05:26 EDTREGNRegeneron, Sanofi announce dupilumab Phase 2b study met primary endpoint
Subscribe for More Information
November 10, 2014
15:55 EDTWDCNeedham to hold a conference
Subscribe for More Information
07:23 EDTEQIXRBC Capital to hold a conference
Subscribe for More Information
07:19 EDTREGNCredit Suisse to hold a conference
Subscribe for More Information
November 7, 2014
11:33 EDTEQIXEquinix management to meet with Oppenheimer
Subscribe for More Information
<< 1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use